Detalles de la búsqueda
1.
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis.
Clin Exp Dermatol
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38738503
2.
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Mod Pathol
; 36(12): 100323, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37678673
3.
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.
Haematologica
; 2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994105
4.
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival.
Int J Mol Sci
; 24(12)2023 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373066
5.
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
Int J Mol Sci
; 25(1)2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203288
6.
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951009
7.
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.
Histopathology
; 80(2): 430-442, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948980
8.
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
Hematol Oncol
; 40(1): 57-62, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653277
9.
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.
Hematol Oncol
; 40(5): 864-875, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850118
10.
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Blood
; 134(24): 2159-2170, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562134
11.
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma.
Haematologica
; 106(9): 2405-2416, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817282
12.
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
Mod Pathol
; 33(2): 179-187, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31028364
13.
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
Mod Pathol
; 33(2): 319, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558781
14.
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
Histopathology
; 77(2): 293-302, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043616
15.
Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis.
Clin Sci (Lond)
; 134(10): 1151-1166, 2020 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420596
16.
Cutaneous adverse-events in patients treated with Ibrutinib.
Dermatol Ther
; 33(6): e14190, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32790083
17.
CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma.
Mod Pathol
; 32(1): 37-47, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30140037
18.
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters.
Mod Pathol
; 32(9): 1359-1372, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30976104
19.
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.
Haematologica
; 104(4): 729-737, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381297
20.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325190